Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Probiotics With Lactobacillus Reduce Loss in Spine BMD for Postmenopausal Women

Publish date:: November 13, 2019

Key clinical point: A probiotic treatment of three Lactobacillus strains protected against lumbar spine bone mineral density loss in postmenopausal women.

Major finding: There was a significant reduction in lumbar spine bone mineral density loss for participants who received the probiotic treatment, compared with women in the control group (mean difference, 0.71%; 95% confidence interval, 0.06%-1.35%).

Study details: A double-blind, randomized, placebo-controlled trial of 249 postmenopausal women who received probiotics with three Lactobacillus strains over a period of 12 months.

Disclosures: This study was funded by Probi, which employs two of the study’s authors. Three authors reported being coinventors of a patent involving the effects of probiotics in osteoporosis treatment, and one author is listed as an inventor on a pending patent application on probiotic compositions and uses.

Citation:

Jansson P-A et al. Lancet Rheumatol. 2019 Nov;1(3):e154-162. doi: 10.1016/S2665-9913(19)30068-2.

This Week's Must Reads

Researchers mine free-text diary entries for seizure cluster insights,

Skip CTs for breakthrough seizures in chronic epilepsy,

Bispecific CAR T-cells yield high response rate in relapsed/refractory myeloma,

In UC patients, tofacitinib tied to modest, reversible lipid increases, infrequent cardiovascular events,

No clear-cut evidence of vedolizumab effect in retrospective study of primary sclerosing cholangitis,

Must Reads in Rheumatology

Certolizumab may reduce uveitis flares, axSpA disease activity,

TULIP trials show clinical benefit of anifrolumab for SLE,

Upadacitinib Doubles ASAS 40 Response VS. Placebo in Ankylosing Spondylitis,

Certolizumab Safety Profile Varies Widely Across Indications,

Large Population-Based Study Underscores Link Between Gout, CVD Event Risk,